WELL Health
Trending >

Blackline Safety is a misunderstood innovator, Ventum says

BLN stock

“A misunderstood innovator”.

That’s what Ventum Capital Markets analyst Amr Ezzat thinks about Blackline Safety (Blackline Safety Stock Quote, Chart, News, Analysts, Financials TSX:BLN).

In a research report to clients September 4, Ezzat resumed coverage (the analyst has a long history with the name, coverage of the stock was suspended during the merger of PI and Echelon to form Ventum Capital) with a “Buy” rating and price target of $6.50, implying a return of 41.3% at the time of publication.

The analyst listed the reasons he like the name, including what he described as a “relentless focus on product development”.

“BLN has consistently reinvested around 26% of its sales into product development since F2014, resulting in a differentiated product line and a three- to five-year technological lead over competitors,” Ezzat wrote. “This focus on innovation is central to the Company’s growth strategy. We project a top-line CAGR of 25.5% over our forecast period through best-in-class net dollar retention (130% last quarter), significantly outpacing industry growth rates. Blackline has emerged as one of Canada’s highest-growth tech companies over the past several years.”

Ezzat says he also likes BLNs expanding gross margins, proven leadership and strong balance sheet.

Regarding his label on BLN as a “misunderstood innovator” the analyst explained that this means opportunity for investors, as he sees a “valuation disconnect”.

“Despite a significant three- to five-year lead over competitors, the market underestimates BLN, primarily viewing it as a hardware provider to the oil and gas industry,” he argued. “In reality, ~75% of its business now comes from outside Canada (up from ~35% in F2015), with exposure to oil and gas reduced to 40% (from 55% in F2015). The Company’s products are highly configurable for multiple industries and applications, thus driving diversified, recurring revenue streams.”

Ezzat thinks BLN will post an Adjusted EBITDA loss of $5.8-million on revenue of $128.7-million in fiscal 2024. He expects those numbers will improve to EBITDA of positive $6.7-million on a topline of $163.3-million in fiscal 2025.

“We expect the Company to grow its sales nearly twofold by F2026 and become EBITDA breakeven by Q4/F24; as such, we believe using multiples on short-term estimates significantly (and incorrectly) undervalues BLN shares as they give no recognition to the Company’s growth profile,” he added. “We derive our $6.50/shr target price using a DCF analysis with a 10.0% discount rate and a 3.0% perpetual growth rate. Our DCF analysis is further corroborated by a comparables benchmarking analysis. With ~53% of sales coming from service revenues that are recurring, we feel it is more appropriate to contrast BLN’s multiples to other Canadian high-visibility tech companies. BLN’s 2.5x/5.7x NTM sales/LTM GP multiples compare to the peer median of 4.6x/7.3x (46%/22% discount), an unwarranted discount in our opinion. For reference, our DCF-derived target price implies a 3.1x/2.6x/2.2x F2025/F2026/F2027 revenue multiple.”

About The Author /

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.
insta twitter facebook

Comment